← Back to Search

Auditory Feedback for Gait Improvement

N/A

Waitlist Available

Led By Dobromir Dotov, PhD

Research Sponsored by University of Nebraska

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up the time frame to measure changes in the outcome variable is two weeks, from the first to last measurement. the time frame to obtain one sample is a few minutes of walking.

Awards & highlights

Study Summary

This trial will explore the role of sound in movement stability, by testing if restricting or augmenting auditory feedback from footsteps can improve movement. Eligibility based on incl/excl criteria (19-35, no hearing/mobility/neurological impairments). 5 visits in 2wks, 1st & last for pre/post comparison.

Who is the study for?

This trial is for individuals who can exercise for 30 minutes and walk comfortably for the same duration. It's not suitable for pregnant women, those with back or leg injuries, surgeries affecting mobility, neurological issues that limit walking ability, or known hearing or visual impairments.Check my eligibility

What is being tested?

The study investigates how sounds made during activities like walking influence movement stability and adaptability. Participants' auditory feedback from their footsteps will be either restricted or augmented to see if it improves their gait.See study design

What are the potential side effects?

Since this trial involves non-invasive auditory feedback manipulation rather than medication or surgery, significant side effects are not anticipated. However, some participants might experience discomfort with altered hearing of their footsteps.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ the time frame to measure changes in the outcome variable is two weeks, from the first to last measurement. the time frame to obtain one sample is a few minutes of walking.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~the time frame to measure changes in the outcome variable is two weeks, from the first to last measurement. the time frame to obtain one sample is a few minutes of walking.

This trial's timeline: 3 weeks for screening, Varies for treatment, and the time frame to measure changes in the outcome variable is two weeks, from the first to last measurement. the time frame to obtain one sample is a few minutes of walking. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Gait instability measured with the maximum Lyapunov exponent (MLE)

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Walking QuietlyExperimental Treatment1 Intervention

Participants instructed to make little noise while walking.

Group II: WalkingActive Control1 Intervention

Walking normally without restriction

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Auditory Feedback

2020

Completed Early Phase 1

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of NebraskaLead Sponsor

539 Previous Clinical Trials

1,144,714 Total Patients Enrolled

Dobromir Dotov, PhDPrincipal InvestigatorUniversity of Nebraska

Media Library

Auditory Feedback Clinical Trial Eligibility Overview. Trial Name: NCT05713383 — N/A

Gait Research Study Groups: Walking, Walking Quietly

Gait Clinical Trial 2023: Auditory Feedback Highlights & Side Effects. Trial Name: NCT05713383 — N/A

Auditory Feedback 2023 Treatment Timeline for Medical Study. Trial Name: NCT05713383 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research offer participation opportunities to individuals younger than 75 years of age?

"According to the entry requirements, only individuals between 19 and 35 years old can participate in this trial. Ancillary trials are available for those below 18 or above 65, with 13 studies targeting younger people and 30 dedicated towards elderly patients."

Answered by AI

Who is eligible to be a participant in this clinical research?

"This research is enrolling 20 participants in their late teens to mid-thirties who demonstrate a healthy lifestyle. In order to be included, these volunteers must meet the following prerequisites: self-reported capacity for 30 minutes of exercise and an ability to walk comfortably for half an hour."

Answered by AI

What is the current status of enrollment for this study?

"This specific clinical trial is no longer enrolling participants, as indicated on the website of clinicaltrials.gov. Initially published in February 1st 2023 and edited for the last time on January 26th 2023, 43 other studies are currently open to applicants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Role of Perturbed Auditory Information for Self-motion in Gait

Dobromir Dotov 2024. "The Role of Perturbed Auditory Information for Self-motion in Gait". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05713383.